Ingredient or product comparison
GHK-cu versus argireline and Matrixyl
Argireline (acetyl hexapeptide-3) and Matrixyl (palmitoyl pentapeptide-4) are the most frequently cited cosmetic peptide alternatives. Both are topical compounds. Argireline functions as a localized neuromodulator by inhibiting the SNARE complex involved in ne
This source-based comparison does not add ratings or recommend a winner.
- Argireline (acetyl hexapeptide-3) and Matrixyl (palmitoyl pentapeptide-4) are the most frequently cited cosmetic peptide alternatives. Both are topical compounds. Argireline functions as a localized neuromodulator by inhibiting the SNARE complex involved in neurotransmitter release, with proposed effects on expression lines; its mechanism is fundamentally different from GHK-Cu's tissue-remodeling activity. Matrixyl stimulates collagen and fibronectin synthesis through TGF-beta pathway activation. Neither has been studied in injectable formulations. GHK-Cu has a longer and more extensive research history than either alternative, and its gene-expression breadth across tissue-remodeling pathways is better characterized. The choice between these compounds is formulation- and delivery-dependent; none has RCT evidence in injectable cosmetic use.